Nicotinamide riboside supplement did not improve Parkinson’s condition in Norway — News-Medical
UA.NEWS13 Oct · 10:34← Topics · 13 Oct
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
As it stood that day
A year-long trial found an NAD-boosting supplement did not improve early Parkinson’s symptoms.
9 reports · 13 Oct
Summary · from headlines2 points
- A 173-trial analysis says exercise type and dose shape motor symptoms; over 8 hours weekly may help slow Parkinson's disease.
- The year-long NOPARK trial found nicotinamide riboside worsened outcomes versus placebo in early Parkinson disease.
Latest developments6 to read first
NOPARK trial finds nicotinamide riboside worsens outcomes versus placebo in early Parkinson disease
AllSci13 Oct · 10:14Year-long trial finds NAD-boosting supplement fails to improve early Parkinson's symptoms
News-Medical13 Oct · 10:14New drug shows multiple improvements for people with Parkinson's disease
FirstWord Pharma13 Oct · 08:54Nanostructure-assisted ultrasound shows potential for Parkinson's treatment
Phys.org13 Oct · 08:14Drug combination that reduces oxygen levels in tissues improves Parkinson's symptoms in mice
Medical Xpress13 Oct · 03:34Timeline 9 reports
13 Oct 20269 reports
10:003 reports
09:00nothing heard
08:002 reports
07:00nothing heard
06:00nothing heard
05:00nothing heard
04:00nothing heard
03:001 report
02:00nothing heard
01:003 reports
← Topics · 13 OctOne topic